Novome Biotechnologies

Developer of gene therapies to treat GI diseases

placeSan Francisco, California, United States calendar_todayFounded 2015 groups44 employees language novomebio.com

Registered entities

Investor mix

12 investors on record; lead investors include DCVC, Tencent.

Investor typeCountShare
Venture capital542%
Other / undisclosed758%
Coming soon